JP2018530595A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530595A5
JP2018530595A5 JP2018519749A JP2018519749A JP2018530595A5 JP 2018530595 A5 JP2018530595 A5 JP 2018530595A5 JP 2018519749 A JP2018519749 A JP 2018519749A JP 2018519749 A JP2018519749 A JP 2018519749A JP 2018530595 A5 JP2018530595 A5 JP 2018530595A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
ethyl
imidazo
pyrazole
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530595A (ja
JP6860559B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/057135 external-priority patent/WO2017066633A1/en
Publication of JP2018530595A publication Critical patent/JP2018530595A/ja
Publication of JP2018530595A5 publication Critical patent/JP2018530595A5/ja
Priority to JP2021053182A priority Critical patent/JP7090770B2/ja
Application granted granted Critical
Publication of JP6860559B2 publication Critical patent/JP6860559B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519749A 2015-10-16 2016-10-14 Ep4アンタゴニスト Active JP6860559B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021053182A JP7090770B2 (ja) 2015-10-16 2021-03-26 Ep4アンタゴニスト

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562242748P 2015-10-16 2015-10-16
US201562242734P 2015-10-16 2015-10-16
US62/242,734 2015-10-16
US62/242,748 2015-10-16
BD2522016 2016-10-13
BD252/2016 2016-10-13
PCT/US2016/057135 WO2017066633A1 (en) 2015-10-16 2016-10-14 Ep4 antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021053182A Division JP7090770B2 (ja) 2015-10-16 2021-03-26 Ep4アンタゴニスト

Publications (3)

Publication Number Publication Date
JP2018530595A JP2018530595A (ja) 2018-10-18
JP2018530595A5 true JP2018530595A5 (enExample) 2019-11-28
JP6860559B2 JP6860559B2 (ja) 2021-04-14

Family

ID=58518017

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018519749A Active JP6860559B2 (ja) 2015-10-16 2016-10-14 Ep4アンタゴニスト
JP2021053182A Active JP7090770B2 (ja) 2015-10-16 2021-03-26 Ep4アンタゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021053182A Active JP7090770B2 (ja) 2015-10-16 2021-03-26 Ep4アンタゴニスト

Country Status (11)

Country Link
US (3) US10316040B2 (enExample)
EP (1) EP3362454B1 (enExample)
JP (2) JP6860559B2 (enExample)
KR (1) KR102684436B1 (enExample)
CN (1) CN108473497B (enExample)
AU (1) AU2016338679B2 (enExample)
BR (1) BR112018007664B1 (enExample)
CA (1) CA3002144C (enExample)
IL (1) IL258737A (enExample)
MX (1) MX390051B (enExample)
WO (1) WO2017066633A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
TWI768043B (zh) 2017-05-18 2022-06-21 瑞士商愛杜西亞製藥有限公司 N-取代吲哚衍生物
US11839613B2 (en) 2017-05-18 2023-12-12 Idorsia Pharmaceuticals Ltd Pyrimidine derivatives as PGE2 receptor modulators
PE20191814A1 (es) 2017-05-18 2019-12-27 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
TW201900179A (zh) 2017-05-18 2019-01-01 瑞士商愛杜西亞製藥有限公司 作為pge2受體調節劑之苯并呋喃及苯并噻吩衍生物
KR102612140B1 (ko) 2017-05-18 2023-12-08 이도르시아 파마슈티컬스 리미티드 피리미딘 유도체
CN111727044A (zh) * 2018-02-05 2020-09-29 深圳市原力生命科学有限公司 用于治疗癌症或炎性疾病的杂二环羧酸
EP3759114A4 (en) * 2018-03-02 2021-12-15 Shenzhen Ionova Life Science Co., Ltd. HETEROBICYCLIC CARBONIC ACIDS AND SALT THEREOF
US12240812B2 (en) 2019-01-22 2025-03-04 Keythera (Suzhou) Pharmaceuticals Co. Ltd. Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation method therefor, and medical uses thereof
US20230390303A1 (en) 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE294943C (enExample)
GB8426447D0 (en) 1984-10-19 1984-11-28 Kodak Ltd Photographic colour couplers
JPS6296940A (ja) 1985-10-24 1987-05-06 Fuji Photo Film Co Ltd 熱現像感光材料
US4847256A (en) 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
US4963553A (en) 1986-10-16 1990-10-16 American Cyanamid Co. 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrahydro-7-[(substituted)phenyl]pyrazolo[1,5-a]pyrimidines
US5126340A (en) 1986-10-16 1992-06-30 American Cyanamid Company 4-[(substituted)alkylcarbonyl]-4,5-dihydro and -4,5,6,7-tetrahydro-7-[(substituted)-phenyl]pyrazolo[1,5-a]pyrimidine-3-carbonitriles
US5215982A (en) 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DD294943A5 (de) 1990-06-05 1991-10-17 Wilhelm-Pieck-Uni. Rostock Direktorat Fuer Forschung,De Verfahren zur herstellung von kondensierten n-heterocyclen
JP2631160B2 (ja) 1990-11-06 1997-07-16 富士写真フイルム株式会社 シアンカプラー、シアン画像形成方法及びハロゲン化銀カラー写真感光材料
JPH04190348A (ja) 1990-11-26 1992-07-08 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
US5210200A (en) 1990-11-29 1993-05-11 Fuji Photo Film Co., Ltd. Heterocyclic dye compounds
US5880066A (en) 1990-12-11 1999-03-09 Monsanto Company Safened herbicidal sulfonamide compositions
US5484760A (en) 1990-12-31 1996-01-16 Monsanto Company Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
TW274551B (enExample) 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
TW284688B (enExample) 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
JP2893100B2 (ja) 1991-11-27 1999-05-17 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
JP2772884B2 (ja) 1992-01-28 1998-07-09 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
JPH05341430A (ja) 1992-06-12 1993-12-24 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5405969A (en) 1993-12-10 1995-04-11 Eastman Kodak Company Manufacture of thioether compounds
US6472416B1 (en) 1999-08-27 2002-10-29 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
JP4233238B2 (ja) 2000-07-06 2009-03-04 富士フイルム株式会社 インク用着色微粒子分散物、それを用いたインクジェット記録用インクおよびインクジェット記録方法
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
DE50207103D1 (en) 2001-03-14 2006-07-20 Gruenenthal Gmbh Substituierte pyrazolo- und thiazolopyrimidine als analgetika
US6783558B2 (en) 2001-03-15 2004-08-31 Kao Corporation Hair coloring method and composition
WO2003004497A1 (en) 2001-07-05 2003-01-16 Sumitomo Pharmaceuticals Company, Limited Novel heterocyclic compound
JP2003222985A (ja) 2001-11-22 2003-08-08 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の感度を増加させる方法
JP2003327860A (ja) 2002-05-09 2003-11-19 Konica Minolta Holdings Inc 着色組成物、着色微粒子分散物、インクジェット用インク、インクジェット記録方法
EP1572113B1 (en) 2002-08-26 2017-05-17 Takeda Pharmaceutical Company Limited Calcium receptor modulating compound and use thereof
JP2004091369A (ja) 2002-08-30 2004-03-25 Sumitomo Pharmaceut Co Ltd 新規ビフェニル化合物
WO2004035563A1 (en) 2002-10-17 2004-04-29 Syngenta Participations Ag 3-heterocyclylpyridine derivatives useful as herbicides
WO2004035564A1 (en) 2002-10-17 2004-04-29 Syngenta Participations Ag Pyridine derivatives useful as herbicides
JP4608869B2 (ja) 2002-12-12 2011-01-12 コニカミノルタホールディングス株式会社 光電変換材料用半導体、光電変換素子及び太陽電池
JP2004277337A (ja) * 2003-03-14 2004-10-07 Sumitomo Pharmaceut Co Ltd ピラゾロ[1,5−a]ピリミジン誘導体
JP4419421B2 (ja) 2003-04-15 2010-02-24 コニカミノルタホールディングス株式会社 光電変換材料用半導体、光電変換素子及び太陽電池
JP4419424B2 (ja) 2003-04-17 2010-02-24 コニカミノルタホールディングス株式会社 光電変換材料用半導体、光電変換素子及び太陽電池
JP2004355960A (ja) 2003-05-29 2004-12-16 Konica Minolta Holdings Inc 光電変換材料用半導体、光電変換素子及び太陽電池
JP2005035932A (ja) 2003-07-15 2005-02-10 Fuji Photo Film Co Ltd 4−置換ピラゾロ[1,5−a]ピリミジンジオン誘導体の製造方法
US7419978B2 (en) 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
JP2005239611A (ja) 2004-02-25 2005-09-08 Takeda Chem Ind Ltd ピラゾロピリミジン誘導体およびその用途
US7288123B2 (en) 2004-08-26 2007-10-30 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
AU2005280115A1 (en) 2004-08-26 2006-03-09 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
DE602005026553D1 (de) 2004-10-12 2011-04-07 Decode Genetics Ehf Peri-substituierte bicyclische sulfonamide gegen arterielle verschlusskrankheit
CN101076531A (zh) * 2004-10-12 2007-11-21 解码遗传学公司 用于阻塞性血管疾病的羧酸迫位取代的双环化合物
JP2006248195A (ja) 2005-03-14 2006-09-21 Fuji Photo Film Co Ltd 感熱記録材料
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
WO2007058626A1 (en) 2005-11-16 2007-05-24 S*Bio Pte Ltd Indazole compounds
WO2007102531A1 (ja) 2006-03-08 2007-09-13 Takeda Pharmaceutical Company Limited 併用薬
ES2392192T3 (es) * 2006-04-24 2012-12-05 Merck Canada Inc. Derivados de indol amida como antagonistas del receptor EP4
WO2008019309A1 (en) 2006-08-04 2008-02-14 Metabasis Therapeutics, Inc. Novel inhibitors of fructose 1,6-bisphosphatase
CA2679175C (en) 2007-02-26 2015-01-13 Merck Frosst Canada Ltd. Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists
US8063249B1 (en) 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
JP5151684B2 (ja) 2008-05-23 2013-02-27 コニカミノルタビジネステクノロジーズ株式会社 トナーの製造方法およびトナー
JP2009282350A (ja) 2008-05-23 2009-12-03 Konica Minolta Business Technologies Inc 静電荷像現像用トナー
JP2010026048A (ja) 2008-07-16 2010-02-04 Konica Minolta Business Technologies Inc カラートナー
JP5536773B2 (ja) * 2008-08-14 2014-07-02 ベータ・ファーマ・カナダ・インコーポレイテッド Ep4受容体アンタゴニストとしてのヘテロ環式アミド誘導体
US20110230472A1 (en) 2008-08-29 2011-09-22 Shionogi & Co., Ltd. Ring-fused azole derivative having pi3k-inhibiting activity
EP2346335B1 (en) 2008-09-24 2018-11-14 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010048559A2 (en) 2008-10-24 2010-04-29 Calcimedica Inc. Phenylpyrazole inhibitors of store operated calcium release
WO2010096115A1 (en) 2008-10-29 2010-08-26 Apath, Llc Compounds, compositions and methods for control of hepatitis c viral infections
WO2010053583A2 (en) 2008-11-10 2010-05-14 Dana Farber Cancer Institute Small molecule cd4 mimetics and uses thereof
CN101671336B (zh) 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
US20120295845A1 (en) 2009-11-23 2012-11-22 Pfizer Inc Imidazo-pyrazoles as gpr119 inhibitors
US9457084B2 (en) * 2010-02-22 2016-10-04 Raqualia Pharma Inc. Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases
ES2540867T3 (es) 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
WO2011156632A2 (en) 2010-06-09 2011-12-15 Georgetown University Compositions and methods of treatment for tumors in the nervous system
EP2611804A1 (en) 2010-09-03 2013-07-10 Forma TM, LLC. Novel compounds and compositions for the inhibition of nampt
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
PE20131343A1 (es) 2010-09-21 2013-11-18 Eisai Randd Man Co Ltd Derivados de acido benzoico
WO2012103071A2 (en) 2011-01-25 2012-08-02 Eisai R&D Management Co., Ltd. Compounds and compositions
CA2826464C (en) 2011-03-02 2020-07-28 Lead Discovery Center Gmbh Pharmaceutically active disubstituted triazine derivatives
CN103596958A (zh) 2011-04-20 2014-02-19 葛兰素集团有限公司 用作抗结核病化合物的四氢吡唑并[1,5-a]嘧啶
DK2729445T3 (en) 2011-07-04 2016-01-18 Rottapharm Biotech Srl CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS
WO2013036994A1 (en) 2011-09-16 2013-03-21 Biota Scientific Management Pty Ltd Compounds for the treatment of hcv
US9169205B2 (en) 2012-10-08 2015-10-27 Boehringer Ingelheim International Gmbh Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
CN102977106B (zh) 2012-12-12 2014-12-10 中国药科大学 一类具有外周镇痛作用的κ阿片受体激动剂
CA2902686C (en) 2013-04-25 2017-01-24 Beigene, Ltd. Fused heterocyclic compounds as protein kinase inhibitors
CA2913035C (en) 2013-05-20 2017-08-01 University Of Washington Through Its Center For Commercialization 5-aminopyrazole-4-carboxamide inhibitors of cdpk1
JP5954278B2 (ja) 2013-08-09 2016-07-20 コニカミノルタ株式会社 静電荷像現像用トナー、その製造方法および画像形成方法
FR3014687B1 (fr) 2013-12-13 2016-11-25 Oreal Procede de coloration des matieres keratiniques a partir d'oligomeres et/ou de polymeres colores issus de coupleurs, composition et agent de coloration
AU2015264102C1 (en) 2014-05-23 2020-10-08 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of cancer
WO2016088903A1 (en) 2014-12-05 2016-06-09 Takeda Pharmaceutical Company Limited Heterocyclic compounds

Similar Documents

Publication Publication Date Title
JP2018530595A5 (enExample)
JP2021100969A5 (enExample)
US12234221B2 (en) Pyridine carboxamide compounds for inhibiting NAV1.8
JP2004511469A5 (enExample)
RU2424242C2 (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
JP2022184886A5 (enExample)
JP2017535561A5 (enExample)
JP2020521730A5 (enExample)
JP2014526501A5 (enExample)
JP2020520356A5 (enExample)
RU2019111882A (ru) Антагонисты trpv4
JP2021508686A5 (enExample)
JP2018517752A5 (enExample)
IL295487A (en) gcn2 modulator compounds
HRP20160112T1 (hr) HETEROARIL SUPSTITUIRANI PIROLO[2,3-b]PIRIDINI I PIROLO[2,3-b]PIRIMIDINI KAO INHIBITORI JANUS KINAZE
JP2016520118A5 (enExample)
JP2003535864A5 (enExample)
JP2011501735A5 (enExample)
JP2009523812A5 (enExample)
JP2014527511A5 (enExample)
JP2014513704A5 (enExample)
HRP20171454T1 (hr) Fuzionirani heterociklični spojevi kao modulatori ionskih kanala
JP2009516685A5 (enExample)
JP2024515243A5 (enExample)
RU2017112518A (ru) Пиридоновые и азапиридоновые соединения и способы применения